Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-217,834
Closed -$6.59M 1847
2025
Q4
$6.59M Sell
217,834
-62,716
-22% -$1.54M 0.01% 642
2025
Q3
$5.64M Buy
280,550
+65,460
+30% +$1.37M 0.01% 772
2025
Q2
$5.36M Sell
215,090
-2,397
-1% -$54K 0.01% 761
2025
Q1
$5.1M Sell
217,487
-5,806
-3% -$168K 0.01% 780
2024
Q4
$6.24M Sell
223,293
-13,628
-6% -$365K 0.01% 732
2024
Q3
$4.83M Buy
236,921
+31,310
+15% +$701K 0.01% 886
2024
Q2
$6.07M Buy
205,611
+5,822
+3% +$167K 0.01% 722
2024
Q1
$6.1M Buy
199,789
+17,435
+10% +$492K 0.01% 726
2023
Q4
$4.26M Sell
182,354
-6,391
-3% -$154K 0.01% 841
2023
Q3
$5.58M Sell
188,745
-6,521
-3% -$219K 0.01% 674
2023
Q2
$6.89M Buy
195,266
+183
+0.1% +$5.12K 0.02% 608
2023
Q1
$4.7M Buy
195,083
+26,181
+16% +$607K 0.01% 776
2022
Q4
$3.76M Sell
168,902
-2,833
-2% -$65.6K 0.01% 893
2022
Q3
$4.08M Buy
171,735
+37,530
+28% +$1.01M 0.01% 757
2022
Q2
$3.12M Buy
134,205
+7,442
+6% +$200K 0.01% 906
2022
Q1
$5.32M Buy
+126,763
New +$6.61M 0.01% 741

Other funds holding CFLT

Canada Life's CFLT Position: Q1 2026 in Review

Canada Life sold out of Confluent (CFLT) in Q1 2026, closing a stake of 217,834 shares — an estimated $6.59M sold.

Canada Life first reported a position in CFLT in Q1 2022 and held it in 16 quarters. The position peaked at $6.89M in Q2 2023. 4 funds tracked by Wall St. Rank hold CFLT as of Q1 2026.

  • Canada Life reported no remaining Confluent position as of Q1 2026 after selling out during the quarter.
  • Canada Life sold 217,834 Confluent shares in Q1 2026, an estimated $6.59M.
  • Canada Life first reported a position in Confluent in Q1 2022 and held it in 16 quarters.
  • Canada Life's Confluent position peaked at $6.89M in Q2 2023.
  • 4 funds tracked by Wall St. Rank held Confluent as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.